Vantage Investment Advisors’s BiondVax Pharmaceuticals Ltd. BVXVW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $14K | Hold |
12,000
| – | – | ﹤0.01% | 484 |
|
|
2018
Q2 | $15K | Hold |
12,000
| – | – | ﹤0.01% | 476 |
|
|
2018
Q1 | $14K | Hold |
12,000
| – | – | ﹤0.01% | 504 |
|
|
2017
Q4 | $17K | Hold |
12,000
| – | – | ﹤0.01% | 481 |
|
|
2017
Q3 | $19K | Hold |
12,000
| – | – | ﹤0.01% | 448 |
|
|
2017
Q2 | $31K | Hold |
12,000
| – | – | 0.01% | 349 |
|
|
2017
Q1 | $17K | Hold |
12,000
| – | – | 0.01% | 436 |
|
|
2016
Q4 | $4K | Hold |
12,000
| – | – | ﹤0.01% | 662 |
|
|
2016
Q3 | $6K | Hold |
12,000
| – | – | ﹤0.01% | 592 |
|
|
2016
Q2 | $5K | Hold |
12,000
| – | – | ﹤0.01% | 631 |
|
|
2016
Q1 | $7K | Hold |
12,000
| – | – | ﹤0.01% | 585 |
|
|
2015
Q4 | $9K | Hold |
12,000
| – | – | ﹤0.01% | 532 |
|
|
2015
Q3 | $10K | Buy |
+12,000
| New | +$10K | 0.01% | 501 |
|